Results 1 to 10 of about 320,868 (341)

Rectal cancer [PDF]

open access: yesCritical Reviews in Oncology/Hematology, 2009
Rectal cancer is an important tumour from an epidemiological point of view and represents the benchmark for an optimal use of integrated treatments (surgery, radiotherapy and chemotherapy) in the oncological practice. The conventional use of total mesorectal excision and the integration with radiochemotherapy, better if preoperatively, are now able to ...
M. G. Zampino   +9 more
  +6 more sources

Use of a Powered Circular Stapler Can Prevent Anastomotic Air Leakage in Robotic Low Anterior Resection for Rectal Cancer

open access: yesJournal of the Anus, Rectum and Colon, 2023
Objectives: Preventing anastomotic complications during rectal cancer surgery is important. Compared with a manual circular stapler, a powered circular stapler is expected to reduce undesirable tension during anastomosis.
Kenji Nanishi   +7 more
doaj   +1 more source

Comparison between robotic‐assisted and laparoscopic sphincter‐preserving operations for ultra‐low rectal cancer

open access: yesAnnals of Gastroenterological Surgery, 2022
Aim Sphincter‐preserving operations for ultra‐low rectal cancer include low anterior and intersphincteric resection. In low anterior resection, the distal rectum is divided by a transabdominal approach, which is technically demanding. In intersphincteric
Tadahiro Kojima   +7 more
doaj   +1 more source

The Effectiveness of Machine Learning in Predicting Lateral Lymph Node Metastasis From Lower Rectal Cancer: A Single Center Development and Validation Study

open access: yesAnnals of Gastroenterological Surgery, 2022
Aim Accurate preoperative diagnosis of lateral lymph node metastasis (LLNM) from lower rectal cancer is important to identify patients who require lateral lymph node dissection (LLND).
Shunsuke Kasai   +8 more
doaj   +1 more source

Survival and Operative Outcomes After Salvage Surgery for Recurrent or Persistent Anal Cancer [PDF]

open access: yesAnnals of Coloproctology, 2020
Anal squamous cell carcinoma (SCC) is a relatively rare cancer comprising less than 2.5% of all gastrointestinal malignancies. The standard treatment for anal SCC is primary chemoradiation therapy which can result in complete regression. After successful
In Ja Park, George Chang
doaj   +1 more source

Mandatory multidisciplinary approach for the evaluation of the lymph node status in rectal cancer [PDF]

open access: yes, 2018
Colorectal cancer is the third most frequently reported malignancy and also the third leading cancer-related cause of death worldwide. Lymph node evaluation, both preoperatively and postoperatively, represents an important aspect of the diagnosis and ...
Ciorbagiu, Mihai C.   +5 more
core   +7 more sources

Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer. [PDF]

open access: yes, 2016
Dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2) is a member of dual-specificity kinase family, which could phosphorylate both Ser/Thr and Tyr substrates. The role of DYRK2 in human cancer remains controversial.
Chu, Zhonghua   +7 more
core   +8 more sources

Primary Tumor Resection for Rectal Cancer With Unresectable Liver Metastases: A Chance to Cut Is a Chance for Improved Survival

open access: yesFrontiers in Oncology, 2021
Background: About half of the patients with rectal cancer will develop liver metastasis during the course of their illness. Unfortunately, a large proportion of these metastases are unresectable. Surgical resection of the primary tumor vs.
Jia-nan Chen   +8 more
doaj   +1 more source

Comprehensive Analysis of miRNA-Mediated Regulatory Network and Identification of Prognosis Biomarkers in Rectal Cancer

open access: yesFrontiers in Genetics, 2022
Rectal cancer is a malignant tumor with poor prognosis. Identification of prognostic biomarkers is needed to improve overall survival of rectal cancer patients. Here, we firstly identified miR-20a-5p significantly classifying high-risk group and low-risk
Tingting Tang   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy